Search | IOVS | ARVO Journals

Showing 1 – 20 of 48

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Perspective February 2022

Consensus Recommendation for Mouse Models of Ocular Hypertension to Study Aqueous Humor Outflow and Its Mechanisms

PDF

Colleen M. McDowell; Krishnakumar Kizhatil; Michael H. Elliott; Darryl R. Overby; Joseph van Batenburg-Sherwood; J. Cameron Millar; Markus H. Kuehn; Gulab Zode; Ted S. Acott; Michael G. Anderson; Sanjoy K. Bhattacharya; Jacques A. Bertrand; Terete Borras; Diane E. Bovenkamp; Lin Cheng; John Danias; Michael Lucio De Ieso; Yiqin Du; Jennifer A. Faralli; Rudolf Fuchshofer; Preethi S. Ganapathy; Haiyan Gong; Samuel Herberg; Humberto Hernandez; Peter Humphries; Simon W. M. John; Paul L. Kaufman; Kate E. Keller; Mary J. Kelley; Ruth A. Kelly; David Krizaj; Ajay Kumar; Brian C. Leonard; Raquel L. Lieberman; Paloma Liton; Yutao Liu; Katy C. Liu; Navita N. Lopez; Weiming Mao; Timur Mavlyutov; Fiona McDonnell; Gillian J. McLellan; Philip Mzyk; Andrews Nartey; Louis R. Pasquale; Gaurang C. Patel; Padmanabhan P. Pattabiraman; Donna M. Peters; Vijaykrishna Raghunathan; Ponugoti Vasantha Rao; Naga Rayana; Urmimala Raychaudhuri; Ester Reina-Torres; Ruiyi Ren; Douglas Rhee; Uttio Roy Chowdhury; John R. Samples; E. Griffen Samples; Najam Sharif; Joel S. Schuman; Val C. Sheffield; Cooper H. Stevenson; Avinash Soundararajan; Preeti Subramanian; Chenna Kesavulu Sugali; Yang Sun; Carol B. Toris; Karen Y. Torrejon; Amir Vahabikashi; Janice A. Vranka; Ting Wang; Colin E. Willoughby; Chen Xin; Hongmin Yun; Hao F. Zhang; Michael P. Fautsch; Ernst R. Tamm; Abbot F. Clark; C. Ross Ethier; W. Daniel Stamer
TAGS: eye, mice, ocular hypertension, intraocular pressure, perfusion
Invest. Ophthalmol. Vis. Sci.. 2022; 63(2):12. doi: https://doi.org/10.1167/iovs.63.2.12

Perspective May 2019

Antibodies Used to Detect Glaucoma-Associated Myocilin: More or Less Than Meets the Eye?

PDF

Athéna C. Patterson-Orazem; Raquel L. Lieberman
TAGS: antibodies, glaucoma, myoc gene, eye
Invest. Ophthalmol. Vis. Sci.. 2019; 60(6):2034-2037. doi: https://doi.org/10.1167/iovs.19-26843

ARVO Annual Meeting Abstract July 2018

Molecular details of protein misfolding in myocilin-associated glaucoma

Raquel L. Lieberman

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5. doi:

Glaucoma October 2017

Myocilin Regulates Metalloprotease 2 Activity Through Interaction With TIMP3

PDF

Myung Kuk Joe; Raquel L. Lieberman; Naoki Nakaya; Stanislav I. Tomarev
TAGS: myoc gene, proteins, metalloproteases, eye
Invest. Ophthalmol. Vis. Sci.. 2017; 58(12):5308-5318. doi: https://doi.org/10.1167/iovs.16-20336

ARVO Annual Meeting Abstract June 2017

Outcomes In Type I Retinopathy of Prematurity Treated with Intravitreal Bevacizumab

Brian Savoie; Adnan Mallick; Ronni M Lieberman

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):5538. doi:

ARVO Annual Meeting Abstract June 2017

Molecular architecture of myocilin and structural defects imparted by non-synonymous mutations in its coiled coil domain

Raquel L Lieberman; Shannon E Hill; Elaine Nguyen; Rebecca K Donegan

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4906. doi:

ARVO Annual Meeting Abstract September 2016

Structures of myocilin olfactomedin domain variants provide new clues into its misfolding and elusive function

Raquel L Lieberman; Shannon Hill; Michelle Kwon

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12) doi:

ARVO Annual Meeting Abstract September 2016

Outcomes in Type I Retinopathy of Prematurity treated with intravitreal bevacizumab

Adnan Mallick; Brian Savoie; Ronni M Lieberman

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):6295. doi:

ARVO Annual Meeting Abstract June 2015

Recurrent Central Serous Chorioretinopathy with Steroids

Dipal Shah; Ronni M Lieberman

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1797. doi:

ARVO Annual Meeting Abstract June 2015

Molecular structures of olfactomedin domains from different subfamilies

Raquel L Lieberman; Shannon Hill; Rebecca K Donegan; Elaine Nguyen

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5525. doi:

ARVO Annual Meeting Abstract April 2014

Crystal structure of the olfactomedin domain of myocilin

Raquel L Lieberman; Rebecca Donegan

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5031. doi:

ARVO Annual Meeting Abstract June 2013

Cyst Size Does Not Predict Response to Therapy on OCT Imaging of Macular Edema

Gautam Kamthan; Ronni Lieberman

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):5860. doi:

ARVO Annual Meeting Abstract June 2013

Stabilization of Myocilin with Small Molecules Prevents Its Aggregation

Raquel Lieberman; Shannon Hill; Rebecca Donegan; Katherine Turnage

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):4004. doi:

ARVO Annual Meeting Abstract June 2013

Effect of an Intravitreal Anti-VEGF Injection on the Dynamics of the Anterior Segment

Jonathan Naysan; Tushar Suthar; Ronni Lieberman; Jonathan Jonisch

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):6302. doi:

ARVO Annual Meeting Abstract June 2013

Grp94 and Grp78 can triage distinct mutant myocilin species for clearance or for aggregation

Chad Dickey; Shannon Hill; Stanislav Tomarev; Myung Kuk Joe; Raquel Lieberman; Amirthaa Suntharalingam

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):767. doi:

ARVO Annual Meeting Abstract March 2012

Effect of Intravitreal Bevacizumab (Avastin ®) on the Foveal Retinal Thickness in the Injected and Contralateral Eye in a Diverse Clinic Population

Jonathan Naysan; Khurram M. Chaudhary; Ronni M. Lieberman

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):2942. doi:

ARVO Annual Meeting Abstract March 2012

Retinal Macroaneurysms - Presentation, Comorbidities, Complications, And Management

Mihai Mititelu; Jonathan Naysan; Ronni M. Lieberman

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):951. doi:

ARVO Annual Meeting Abstract March 2012

Effect of Intravitreal Ranibizumab (Lucentis®) on the Foveal and Macular Thickness in the Contralateral Eye in Patients with Neovascular Age Related Macular Degeneration

Tushar Suthar; Ronni M. Lieberman; David Y. Rhee

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):5160. doi:

ARVO Annual Meeting Abstract March 2012

Amyloid Fibril Formation By The Olfactomedin Domain Of Myocilin

Raquel L. Lieberman; Susan D. Orwig; Christopher W. Perry; Laura Y. Kim; Katherine C. Turnage; Rong Zhang; Douglas Vollrath; Ingeborg Schmidt-Krey

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):6317. doi:

ARVO Annual Meeting Abstract April 2011

Effect of Intravitreal Bevacizumab (Avastin®) on Retinal Blood Vessel Diameter in the Injected and Contralateral Eye in a Diverse Clinic Population

Teddy Lyu; Diane Chang; Khurram Chaudhary; Ronni M. Lieberman; Robert M. Fischer

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):1699. doi:

1 2 3

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Consensus Recommendation for Mouse Models of Ocular Hypertension to Study Aqueous Humor Outflow and Its Mechanisms

Antibodies Used to Detect Glaucoma-Associated Myocilin: More or Less Than Meets the Eye?

Molecular details of protein misfolding in myocilin-associated glaucoma

Myocilin Regulates Metalloprotease 2 Activity Through Interaction With TIMP3

Outcomes In Type I Retinopathy of Prematurity Treated with Intravitreal Bevacizumab

Molecular architecture of myocilin and structural defects imparted by non-synonymous mutations in its coiled coil domain

Structures of myocilin olfactomedin domain variants provide new clues into its misfolding and elusive function

Outcomes in Type I Retinopathy of Prematurity treated with intravitreal bevacizumab

Recurrent Central Serous Chorioretinopathy with Steroids

Molecular structures of olfactomedin domains from different subfamilies

Crystal structure of the olfactomedin domain of myocilin

Cyst Size Does Not Predict Response to Therapy on OCT Imaging of Macular Edema

Stabilization of Myocilin with Small Molecules Prevents Its Aggregation

Effect of an Intravitreal Anti-VEGF Injection on the Dynamics of the Anterior Segment

Grp94 and Grp78 can triage distinct mutant myocilin species for clearance or for aggregation

Effect of Intravitreal Bevacizumab (Avastin ®) on the Foveal Retinal Thickness in the Injected and Contralateral Eye in a Diverse Clinic Population

Retinal Macroaneurysms - Presentation, Comorbidities, Complications, And Management

Effect of Intravitreal Ranibizumab (Lucentis®) on the Foveal and Macular Thickness in the Contralateral Eye in Patients with Neovascular Age Related Macular Degeneration

Amyloid Fibril Formation By The Olfactomedin Domain Of Myocilin

Effect of Intravitreal Bevacizumab (Avastin®) on Retinal Blood Vessel Diameter in the Injected and Contralateral Eye in a Diverse Clinic Population

To View More...

You must be signed into an individual account to use this feature.